Medicare Enrolled
Dr. Peter Razeghi, M.D.
Cardiovascular Disease · Cypress, TX
Practice pattern: Cardiac Imaging
— Practice with significant diagnostic imaging and stress testing
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Razeghi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Razeghi?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Razeghi
Dr. Peter Razeghi is a cardiovascular disease specialist in Cypress, TX, with 18 years of NPI registration. Based on federal Medicare data, Dr. Razeghi performed 5,617 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Razeghi received a total of $5,415 from 40 pharmaceutical and/or device companies across 262 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Razeghi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years of NPI registration
▲ Top 14% volume in TX
$5,415 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗5,617
Medicare services
Top 14% in TX for cardiovascular disease
Not available
Unique patients (not deduplicated)
$131
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,016 | $93 | $200 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
714 | $64 | $300 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
682 | $43 | $300 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
644 | $10 | $95 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
391 | $117 | $605 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
290 | $7 | $35 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
248 | $0 | $10 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
211 | $56 | $300 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
170 | $4 | $15 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 157 | $667 | $1,332 |
| Nuclear stress test with CT scan A nuclear medicine imaging test that evaluates blood flow in the heart muscle at rest and during stress, performed alongside a concurrent CT scan. |
155 | $1,928 | $4,500 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
154 | $138 | $552 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
153 | $59 | $155 |
| PET scan of heart muscle blood flow A nuclear medicine imaging test that uses positron emission tomography (PET) to evaluate blood flow within the heart muscle. |
113 | $146 | $500 |
| Physician review of home INR testing A physician reviews, interprets, and manages home INR testing results for patients with mechanical heart valves, chronic atrial fibrillation, or venous thromboembolism who meet Medicare coverage criteria. |
82 | $6 | $25 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
56 | $150 | $600 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
53 | $19 | $82 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
46 | $132 | $263 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
38 | $207 | $1,884 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
38 | $67 | $180 |
| Continuous external EKG monitoring, 48 hours to 7 days This procedure involves recording, analyzing, and interpreting a continuous external electrocardiogram (EKG) over a period of more than 48 hours up to 7 days. |
36 | $203 | $800 |
| 2-day continuous ECG with review and report A two-day continuous electrocardiogram recording that includes a professional review and written report of the results. |
34 | $48 | $395 |
| Emergency department visit, high complexity An emergency department visit involving a high level of medical decision making. |
22 | $144 | $200 |
| Pacemaker system evaluation Assessment of a pacemaker device, including single, dual, multiple lead, or leadless systems. |
21 | $41 | $65 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
20 | $78 | $522 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
17 | $17 | $55 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
17 | $11 | $55 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
17 | $10 | $20 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
11 | $166 | $400 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
11 | $225 | $500 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
11.8% high complexity
21.3% medium
67.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,415
Total received (2018-2024)
Avg $774/year across 7 years
Top 47% in TX for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
40
Companies
262
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$914
2023
$912
2022
$1,031
2021
$1,051
2020
$431
2019
$393
2018
$683
Payments by company (2024)
Boston Scientific Corporation
$189
PFIZER INC.
$142
E.R. Squibb & Sons, L.L.C.
$70
Novartis Pharmaceuticals Corporation
$67
Medtronic, Inc.
$64
Janssen Pharmaceuticals, Inc
$58
Edwards Lifesciences Corporation
$45
Merck Sharp & Dohme LLC
$44
Azurity Pharmaceuticals, Inc.
$42
Amgen Inc.
$40
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$37
AstraZeneca Pharmaceuticals LP
$34
Recor Medical Inc
$25
Kiniksa Pharmaceuticals International, plc
$22
Esperion Therapeutics, Inc.
$19
Lexicon Pharmaceuticals, Inc.
$17
Top 3 companies account for 43.9% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$708
Boston Scientific Corporation
$637
E.R. Squibb & Sons, L.L.C.
$428
Janssen Pharmaceuticals, Inc
$409
Novartis Pharmaceuticals Corporation
$364
Abbott Laboratories
$319
Medtronic, Inc.
$308
Amarin Pharma Inc.
$270
PFIZER INC.
$245
Merck Sharp & Dohme LLC
$240
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$157
Medtronic Vascular, Inc.
$145
Esperion Therapeutics, Inc.
$137
Gilead Sciences, Inc.
$133
AstraZeneca Pharmaceuticals LP
$132
SANOFI-AVENTIS U.S. LLC
$74
BOSTON SCIENTIFIC CORPORATION
$68
Astellas Pharma US Inc
$65
Edwards Lifesciences Corporation
$63
Kowa Pharmaceuticals America, Inc.
$58
Kiniksa Pharmaceuticals, Ltd.
$50
Impulse Dynamics (USA) Inc.
$43
Azurity Pharmaceuticals, Inc.
$42
Arbor Pharmaceuticals, Inc.
$30
Boehringer Ingelheim Pharmaceuticals, Inc.
$25
Recor Medical Inc
$25
Itamar Medical Inc
$25
Kiniksa Pharmaceuticals International, plc
$22
Adhera Therapeutics, Inc.
$20
Actelion Pharmaceuticals US, Inc.
$19
CVRx, Inc.
$18
Preventice Services, LLC
$17
Lexicon Pharmaceuticals, Inc.
$17
ARBOR PHARMACEUTICALS, INC.
$16
Aziyo Biologics, Inc.
$15
InfoBionic, Inc
$15
Merck Sharp & Dohme Corporation
$15
Philips Electronics North America Corporation
$14
AtriCure, Inc.
$14
BIOTRONIK INC.
$14
Top 3 companies account for 32.7% of all-time payments
Associated products mentioned in payments ›
(7999) SRC Undivided · AZURE XT DR MRI SURESCAN · Allure Quadra RF CRT Pacemaker · Arcalyst · Assurity Pacemaker · Azure · BRILINTA · Barostim Neo System · CAMZYOS · CONFIRM RX · CareLink · Confirm Rx · Corlanor · ECM · EDARBI · EDARBYCLOR · ELIQUIS · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · Edarbi · Edarbyclor · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FARXIGA · HeartMate 3 Left Ventricular Dev · LEQVIO · LEXISCAN · LINQ II · LUX DX · LUX-DX · LUX-Dx Insertable Cardiac Monitor · LifeVest · Livalo · MITRACLIP · MRI Ready Leads · MULTAQ · MYCARELINK · Merlin Connectivity and Remote · Micra · Mitra Clip system · MoMe Kardia · NEXLETOL · OPSUMIT · Optimizer · Optimizer Smart System · PARADISE RENAL DENERVATION SYSTEM · PRADAXA · PRALUENT · PRESTALIA · RESONATE · RESONATE EL ICD VR · REVEAL LINQ · Repatha · Reveal LINQ · SAPIEN 3 Ultra RESILIA · VERQUVO · VIGILANT · VYNDAQEL · Vascepa · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · WatchPAT · XARELTO
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Cardiologists in nearby ZIP areas
199
County median income
$73,104
Nearest hospital to ZIP centroid (approximate)
LONE STAR BEHAVIORAL HEALTH CYPRESS
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Razeghi is a cardiac imaging specialist, with above-average Medicare volume (top 14% in TX), with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Razeghi experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Razeghi performed 1,016 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Razeghi receive payments from pharmaceutical companies?
Yes. Dr. Razeghi received a total of $5,415 from 40 companies across 262 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Razeghi's costs compare to other cardiologists in Cypress?
Dr. Razeghi's average Medicare payment per service is $131. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Razeghi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Cypress
Browse cardiologists in Cypress ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in TX
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in TX
Which TX cardiologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology